Donepezil Hydrochloride Orally Disintegrating Tablet 10 mg
Donepezil Hydrochloride Hydrate 10.43mg
Orally disintegrating Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
MFDS item code 201901684 · Approved 2019.03.20
This product's status changed to Approval withdrawn on 2023.10.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of symptoms of Alzheimer's dementia. Alzheimer's dementia is characterized by a decline in memory and cognitive function, and this medication helps alleviate these symptoms and improve the patient's daily functioning. Therefore, it is used to treat dementia symptoms and enhance quality of life.
○ Adults : Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, taking this drug in the morning may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer a dose of 5 mg for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If treatment with this drug is discontinued, its effects gradually decrease; no rebound effect occurs with abrupt discontinuation. This drug is an orally disintegrating tablet; place it on the tongue and allow it to dissolve, then take it with or without water. ○ Female patients aged 85 years or older who are underweight : Careful monitoring is required because adverse reactions occur more frequently. Elderly women who are underweight should not exceed 5 mg daily.
○ Pediatric patients : There is no experience with use in pediatric patients.
This medication should not be used in patients who are hypersensitive to specific ingredients or in women who are pregnant or breastfeeding. Patients with heart disease or heart rhythm issues should use this medication with caution and be alert for cardiac symptoms. Patients with a history of peptic ulcers or who are taking non-steroidal anti-inflammatory drugs should closely monitor their gastrointestinal condition. Patients with asthma or obstructive lung disease should be cautious as this medication might exacerbate respiratory symptoms. Patients with extrapyramidal disorders such as Parkinson's disease should administer this medication carefully due to the possibility of worsening symptoms. This medication can slow down heart rate or cause arrhythmias; therefore, regular monitoring of cardiovascular status is necessary. Severe side effects such as gastrointestinal bleeding, liver dysfunction, seizures, and muscle disorders may occur, so immediate consultation with healthcare providers is required if any unusual symptoms appear. Caution is needed when driving or operating machinery as dizziness or drowsiness may occur. There is a high potential for interactions with other medications, so it is essential to inform the healthcare provider or pharmacist of any other medications being taken. It is safest for pregnant or breastfeeding women not to use this medication; if absolutely necessary, it should be discussed with a healthcare professional. Safety in children has not been established, thus it should not be used in pediatric patients. In cases of overdose, symptoms such as nausea, vomiting, muscle weakness, and difficulty breathing may arise, requiring immediate emergency care. This medication is an orally disintegrating tablet; it is important to let it dissolve completely in the mouth before swallowing.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture from entering. It is also advisable to keep it at room temperature between 1 and 30 degrees Celsius.
Yellow round orally disintegrating tablet
30 tablets (10 tablets/PTP) X 3
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Donepezil Hydrochloride Hydrate 10.43mg
Orally disintegrating Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.